3 Matching Annotations
  1. Last 7 days
    1. If fenebrutinib is not yet available, should ocrelizumab/rituximab be reconsidered as a bridge? (Previously declined, Sep 2025)

      why are we asking this question? we dont think this is a good idea right? and the doctor didnt think so before either.